ClinicalTrials.govpublic full text
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
triple-negative breast cancer, breast cancer, advanced triple negative, ixazomib, carboplatin, carixa, study group of medical tumor therapy (agmt), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873047
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.